Kohn, D. B., Shaw, K. L., Garabedian, E., Carbonaro-Sarracino, D. A., Moore, T. B., De Oliveira, S. N., … Gaspar, H. B. (2020). Lentiviral Gene Therapy with Autologous Hematopoietic Stem and Progenitor Cells (HSPCs) for the Treatment of Severe Combined Immune Deficiency Due to Adenosine Deaminase Deficiency (ADA-SCID): Two Year Follow-Up Results. In MOLECULAR THERAPY (Vol. 28, pp. 554–555).

Kohn, Donald B., Kit L. Shaw, Elizabeth Garabedian, Denise A. Carbonaro-Sarracino, Theodore B. Moore, Satiro N. De Oliveira, Gay M. Crooks, et al. “Lentiviral Gene Therapy with Autologous Hematopoietic Stem and Progenitor Cells (HSPCs) for the Treatment of Severe Combined Immune Deficiency Due to Adenosine Deaminase Deficiency (ADA-SCID): Two Year Follow-Up Results.” In MOLECULAR THERAPY, 28:554–55, 2020.

Kohn DB, Shaw KL, Garabedian E, Carbonaro-Sarracino DA, Moore TB, De Oliveira SN, et al. Lentiviral Gene Therapy with Autologous Hematopoietic Stem and Progenitor Cells (HSPCs) for the Treatment of Severe Combined Immune Deficiency Due to Adenosine Deaminase Deficiency (ADA-SCID): Two Year Follow-Up Results. In: MOLECULAR THERAPY. 2020. p. 554–5.

Kohn, Donald B., et al. “Lentiviral Gene Therapy with Autologous Hematopoietic Stem and Progenitor Cells (HSPCs) for the Treatment of Severe Combined Immune Deficiency Due to Adenosine Deaminase Deficiency (ADA-SCID): Two Year Follow-Up Results.” MOLECULAR THERAPY, vol. 28, no. 4, 2020, pp. 554–55.

Kohn DB, Shaw KL, Garabedian E, Carbonaro-Sarracino DA, Moore TB, De Oliveira SN, Crooks GM, Tse J, Shupien S, Terrazas D, Davila A, Icreverzi A, Yu A, Chun KM, Casas CE, Barman P, Coronel M, Fernandez BC, Zhang R, Hollis RP, Bayford JX, Trevisan V, Arduini S, Lynn F, Kudari M, Uzowuru C, Ricketts H, Spezzi A, Reeves L, Cornetta K, Sokolic RA, Parrott R, Buckley R, Booth C, Candotti F, Malech HL, Thrasher AJ, Gaspar HB. Lentiviral Gene Therapy with Autologous Hematopoietic Stem and Progenitor Cells (HSPCs) for the Treatment of Severe Combined Immune Deficiency Due to Adenosine Deaminase Deficiency (ADA-SCID): Two Year Follow-Up Results. MOLECULAR THERAPY. 2020. p. 554–555.